CASI Pharmaceuticals (ENM) Financial Statements

0 Followers

CASI Pharmaceuticals Financial Overview

CASI Pharmaceuticals's market cap is currently CHF2.53M. The company's EPS TTM is CHF-2.29; its P/E ratio is -0.07; CASI Pharmaceuticals is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	$ 20.71M	$ 28.54M	$ 33.88M	$ 43.11M	$ 30.17M
Gross Profit	$ 10.06M	$ 11.15M	$ 20.05M	$ 27.28M	$ 17.61M
Operating Income	$ -42.85M	$ -39.62M	$ -25.08M	$ -26.49M	$ -41.52M
EBITDA	$ -43.77M	$ -34.87M	$ -21.54M	$ -35.79M	$ -33.40M
Net Income	$ -48.06M	$ -39.26M	$ -26.94M	$ -41.01M	$ -36.65M
Balance Sheet
Cash & Short-Term Investments	$ 5.63M	$ 16.09M	$ 30.77M	$ 51.34M	$ 48.57M
Total Assets	$ 25.65M	$ 53.67M	$ 75.27M	$ 96.23M	$ 138.30M
Total Debt	$ 27.49M	$ 22.14M	$ 21.24M	$ 1.34M	$ 4.33M
Net Debt	$ 21.85M	$ 8.67M	$ 4.16M	$ -45.77M	$ -34.37M
Total Liabilities	$ 62.93M	$ 51.82M	$ 51.10M	$ 29.30M	$ 30.34M
Stockholders' Equity	$ -37.28M	$ 1.85M	$ 24.16M	$ 44.57M	$ 84.50M
Cash Flow
Free Cash Flow	$ -20.77M	$ -29.46M	$ -22.21M	$ -26.70M	$ -42.34M
Operating Cash Flow	$ -20.75M	$ -29.22M	$ -19.97M	$ -21.09M	$ -26.84M
Investing Cash Flow	$ 951.00K	$ 11.24M	$ -9.67M	$ 31.16M	$ -20.69M
Financing Cash Flow	$ 11.25M	$ 15.43M	$ -907.00K	$ -3.27M	$ 29.64M

Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

Income Statement >

CASI Pharmaceuticals Debt to Assets

Balance Sheet >

CASI Pharmaceuticals Cash Flow

Cash Flow >

CASI Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >